Unknown

Dataset Information

0

Roles of Alternative RNA Splicing of the Bif-1 Gene by SRRM4 During the Development of Treatment-induced Neuroendocrine Prostate Cancer.


ABSTRACT: Treatment-induced neuroendocrine prostate cancer (t-NEPC) is an aggressive subtype of prostate cancer (PCa) that becomes more prevalent when hormonal therapy, chemotherapy, or radiation therapy is applied to patients with metastatic prostate adenocarcinoma (AdPC). How AdPC cells survive these anti-cancer therapies and progress into t-NEPC remains unclear. By comparing the whole transcriptomes between AdPC and t-NEPC, we identified Bif-1, an apoptosis-associated gene, which undergoes alternative RNA splicing in t-NEPC. We found that while Bif-1a is the predominant variant of the Bif-1 gene in AdPC, two neural-specific variants, Bif-1b and Bif-1c, are highly expressed in t-NEPC patients, patient derived xenografts, and cell models. The neural-specific RNA splicing factor, SRRM4, promotes Bif-1b and Bif-1c splicing, and the expression of SRRM4 in tumors is strongly associated with Bif-1b/-1c levels. Furthermore, we showed that Bif-1a is pro-apoptotic, while Bif-1b and Bif-1c are anti-apoptotic in PCa cells under camptothecin and UV light irritation treatments. Taken together, our data indicate that SRRM4 regulates alternative RNA splicing of the Bif-1 gene that enables PCa cells resistant to apoptotic stimuli under anti-cancer therapies, and may contribute to AdPC progression into t-NEPC.

SUBMITTER: Gan Y 

PROVIDER: S-EPMC6013970 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Roles of Alternative RNA Splicing of the Bif-1 Gene by SRRM4 During the Development of Treatment-induced Neuroendocrine Prostate Cancer.

Gan Yu Y   Li Yinan Y   Long Zhi Z   Lee Ahn R AR   Xie Ning N   Lovnicki Jessica M JM   Tang Yuxin Y   Chen Xiang X   Huang Jiaoti J   Dong Xuesen X  

EBioMedicine 20180516


Treatment-induced neuroendocrine prostate cancer (t-NEPC) is an aggressive subtype of prostate cancer (PCa) that becomes more prevalent when hormonal therapy, chemotherapy, or radiation therapy is applied to patients with metastatic prostate adenocarcinoma (AdPC). How AdPC cells survive these anti-cancer therapies and progress into t-NEPC remains unclear. By comparing the whole transcriptomes between AdPC and t-NEPC, we identified Bif-1, an apoptosis-associated gene, which undergoes alternative  ...[more]

Similar Datasets

| S-EPMC7218227 | biostudies-literature
| S-EPMC5620142 | biostudies-literature
| S-EPMC8448969 | biostudies-literature
| S-EPMC5438622 | biostudies-literature
2020-05-19 | GSE132062 | GEO
| S-EPMC4387716 | biostudies-literature
| S-EPMC6317919 | biostudies-literature
| S-EPMC6154886 | biostudies-literature
| S-EPMC5247714 | biostudies-literature
2021-07-14 | GSE158599 | GEO